Drospirenone with 17β-estradiol in the postmenopausal woman with hypertension

References

• Kannel W B. Fifty years of Framingham Study contributions to understanding hypertension. J Hum Hypertens 2000; 14: 83–90
   PubMed Web of Science ®Google Scholar
• Franklin S S, Gustin W, 4th, Wong N D, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96: 308–315
   PubMed Web of Science ®Google Scholar
• Chobanian A V, Bakris G L, Black H R, , National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560–2572
   PubMed Web of Science ®Google Scholar
• Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903–1913
   PubMed Web of Science ®Google Scholar
• MacMahon S. Blood pressure and the prevention of stroke. J Hypertens 1996; 14(Suppl)S39–S46
   Google Scholar
• Staessen J A, Wang J G, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001; 358: 1305–1315
   PubMed Web of Science ®Google Scholar
• Regitz-Zagrosek V. Cardiovascular disease in postmenopausal women. Climacteric 2003; 6(Suppl 3)13–20
   PubMedGoogle Scholar
• Hajjar I, Kotchen T A. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 2003; 290: 199–206
   PubMed Web of Science ®Google Scholar
• Staessen J, Bulpitt C J, Fagard R, Lijnen P, Amery A. The influence of menopause on blood pressure. J Hum Hypertens 1989; 3: 427–433
   PubMed Web of Science ®Google Scholar
• Burt V L, Cutler J A, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995; 26: 60–69
   PubMed Web of Science ®Google Scholar
• Whyte J L, Lapuerta P, L'Italien G J, Franklin S S. The challenge of controlling systolic blood pressure: data from the National Health and Nutrition Examination Survey (NHANES III), 1988–1994. J Clin Hypertens 2001; 3: 211–216
   PubMedGoogle Scholar
• Krakoff L R, Phillips R A. White-coat hypertension. Lancet 1996; 348: 1443–1444
   PubMed Web of Science ®Google Scholar
• Millar-Craig M W, Bishop C N, Raftery E B. Circadian variation of blood pressure. Lancet 1978; 1: 795–797
   PubMed Web of Science ®Google Scholar
• White W B. Relevance of blood pressure variation in the circadian onset of cardiovascular events. J Hypertens 2003; 21(Suppl)S9–S15
   Google Scholar
• Hansen T W, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens 2006; 19: 243–250
   PubMed Web of Science ®Google Scholar
• Pickering T G, Hall J E, Appel L J, , Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research, et al. Recommendations for blood pressure measurement in humans and experimental animals. 1. Blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005; 45: 142–161
   PubMed Web of Science ®Google Scholar
• Weber M A. The 24-hour blood pressure pattern: does it have implications for morbidity and mortality?. Am J Cardiol 2002; 89: 27–33A
   PubMed Web of Science ®Google Scholar
• McMahon E G. Recent studies with eplerenone, a novel selective aldosterone receptor antagonist. Curr Opin Pharmacol 2001; 1: 190–196
   PubMedGoogle Scholar
• Struthers A D. The clinical implications of aldosterone escape in congestive heart failure. Eur J Heart Fail 2004; 6: 539–545
   PubMed Web of Science ®Google Scholar
• Conlin P R. Interactions of high salt intake and the response of the cardiovascular system to aldosterone. Cardiol Rev 2005; 13: 118–124
   PubMedGoogle Scholar
• Biollaz J, Brunner H R, Gavras I, Waeber B, Gavras H. Antihypertensive therapy with MK 421: angiotensin II–renin relationships to evaluate efficacy of converting enzyme blockade. J Cardiovasc Pharmacol 1982; 4: 966–972
   PubMed Web of Science ®Google Scholar
• van de Wal R M, Plokker H W, Lok D J, et al. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. Int J Cardiol 2006; 106: 367–372
   PubMed Web of Science ®Google Scholar
• Jeunemaitre X, Chatellier G, Kreft-Jais C, et al. Efficacy and tolerance of spironolactone in essential hypertension. Am J Cardiol 1987; 60: 820–825
   PubMed Web of Science ®Google Scholar
• de Gasparo M, Whitebread S E, Preiswerk G, Jeunemaitre X, Corvol P, Menard J. Antialdosterones: incidence and prevention of sexual side effects. J Steroid Biochem 1989; 32: 223–227
   PubMedGoogle Scholar
• Krattenmacher R. Drospirenone: pharmacology and pharmacokinetics of a unique progestogen. Contraception 2000; 62: 29–38
   PubMed Web of Science ®Google Scholar
• White W B, Carr A A, Krause S, Jordan R, Roniker B, Oigman W. Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension. Am J Cardiol 2003; 92: 38–42
   PubMed Web of Science ®Google Scholar
• Losert W, Casals-Stenzel J, Buse M. Progestogens with antimineralocorticoid activity. Arzneimittelforschung 1985; 35: 459–471
   PubMed Web of Science ®Google Scholar
• Pollow K, Juchem M, Elger W, et al. Dihydrospirorenone (ZK30595): a novel synthetic progesterone – characterization of binding to different receptor proteins. Contraception 1992; 46: 561–574
   PubMed Web of Science ®Google Scholar
• Muhn P, Fuhrmann U, Fritzemeier K H, et al. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Ann NY Acad Sci 1995; 761: 311–335
   PubMed Web of Science ®Google Scholar
• Fuhrmann U, Krattenmacher R, Slater E P, et al. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential. Contraception 1996; 54: 243–251
   PubMed Web of Science ®Google Scholar
• Elger W, Beier S, Pollow K, Garfield R, Shi S Q, Hillisch A. Conception and pharmacodynamic profile of drospirenone. Steroids 2003; 68: 891–905
   PubMed Web of Science ®Google Scholar
• Rocha R, Chander P N, Khanna K, Zuckerman A, Stier C T, Jr. Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. Hypertension 1998; 31: 451–458
   PubMed Web of Science ®Google Scholar
• MacFadyen R J, Barr C S, Struthers A D. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. Cardiovasc Res 1997; 35: 30–34
   PubMed Web of Science ®Google Scholar
• Archer D F, Thorneycroft I H, Foegh M, et al. Long-term safety of drospirenone–estradiol for hormone therapy: a randomized, double-blind, multicenter trial. Menopause 2005; 12: 716–727
   PubMed Web of Science ®Google Scholar
• White W B, Pitt B, Preston R A, Hanes V. Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension. Circulation 2005; 112: 1979–1984
   PubMed Web of Science ®Google Scholar
• European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology Guidelines for the Management of Arterial Hypertension. J Hypertens 2003; 21: 1011–1053
   PubMed Web of Science ®Google Scholar
• White W B, Hanes V, Pitt B, Chauhan V. Effects of a new hormone therapy, drospirenone and 17-beta-estradiol, in postmenopausal women with hypertension. Hypertension 2006; 48: 246–253
   PubMed Web of Science ®Google Scholar